Winter Park, Florida–(Newsfile Corp. – February 16, 2026) – Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its second clinical study for Institutional Review Board (IRB) review. This pivotal study will evaluate the efficacy of AdiaVita, Adia Med’s proprietary umbilical cord blood-derived stem cell and exosome product, in alleviating lower back pain through
Adia Nutrition Announces Subsidiary Adia Med’s Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita
Latest from Blog
Minnesota reaches $18.5 million settlement with nonprofit over child nutrition fraud claims
Partners in Nutrition will dissolve and turn over remaining funds under a consent judgment filed in Hennepin County Post Views: 3
Caitlin Clark turns cereal into a $100,000+ fundraiser: How the WNBA superstar used her platform to support youth programmes away from basketball
Caitlin Clark’s rise has translated off the court as the Indiana Fever star has made more of herself through commercial partnerships and community endeavors. One of the more unique examples has been
The Healthiest Vegetables to Add to Your Grocery List, According to Dietitians
Fresh or frozen, these veggies are a simple way to add fiber and essential vitamins to your diet. Post Views: 3
